The Good, The Bad, and The Ugly of Atrial Fibrillation

Dr. Steven Deitelzweig discusses opportunities for improving anticoagulant management, an evidence-based risk assessment, how pivotal trials and guidelines are used to select oral anticoagulants (OAC). He also provides information on selecting the right OAC for patients, how to manage bleeding events on a OAC, and strategies for an effective transition of care.

Related Articles